Caris Life Sciences insider Halbert now holds 1.37 M CAI shares
Rhea-AI Filing Summary
Form 4 filing overview – Caris Life Sciences, Inc. (CAI)
The filing reports two equity events for director Jon Halbert. The earliest transaction occurred on 02/27/2025, when 16,129 restricted stock units (RSUs) were credited at no cash cost, lifting Halbert’s directly held common-stock balance to 116,129 shares. These RSUs were previously disclosed on the director’s Form 3 and reflect the company’s 1-for-4 reverse split completed 01 June 2025.
The more material event was on 06/20/2025, when 5,000,000 Series A Preferred shares owned through Ke’Ohana Ventures, LLC automatically converted at a 0.25:1 ratio into 1,250,000 CAI common shares upon the closing of the company’s initial public offering. This conversion, coded “C”, was also completed at a stated price of $0 because it was contractual.
Post-conversion, Halbert reports beneficial ownership of 1,366,129 common shares of CAI—116,129 D (direct) and 1,250,000 I (indirect via Ke’Ohana Ventures). No open-market purchases or sales are disclosed, and there is no cash consideration. The filing therefore signals continued insider alignment rather than a change in economic exposure.
Positive
- None.
Negative
- None.
Insights
TL;DR – Automatic preferred-to-common conversion; ownership now 1.37 M CAI shares; neutral cash impact.
The 5 M Series A Preferred shares converting into 1.25 M common shares is a standard IPO clean-up step, not a fresh capital injection. Because the conversion was priced at $0 and triggered automatically, it neither provides cash to the issuer nor signals bullish insider buying. Nonetheless, the resulting 1.37 M-share stake means the director retains a sizeable holding, aligning interests with public shareholders. There are no sales, option exercises, or disposition signals, so market impact should be modest and largely informational.
TL;DR – Disclosure confirms post-IPO capitalization & insider alignment; governance-neutral.
The Form 4 clarifies the equity structure following the one-for-four reverse split and IPO close. Automatic conversion of preferred stock eliminates a senior security class, simplifying the capital stack—positive from a governance clarity standpoint. Halbert’s continued indirect stake via Ke’Ohana Ventures keeps influence concentrated but is fully disclosed; he also disclaims beneficial ownership beyond pecuniary interest. No 10b5-1 plan is invoked, and no Section 16 termination is checked, indicating ongoing reporting obligations. Overall governance impact is neutral: transparency is adequate, and no conflicts are introduced.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series A Preferred Stock | 5,000,000 | $0.00 | -- |
| Conversion | Common Stock | 1,250,000 | $0.00 | -- |
| Grant/Award | Common Stock | 16,129 | $0.00 | -- |
Footnotes (1)
- Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. These restricted stock units were previously reported on the Reporting Person's Form 3. All the securities reported in this Form 4 reflect a one-for-four reverse stock split effected as of June 1, 2025. Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
